The usefulness of multiparametric ultrasound for the assessment of patients with autoimmune hepatitis

Not Applicable

Recruiting

• Conditions: Autoimmune hepatitis

• Registration Number: JPRN-UMIN000051252
• Lead Sponsor: Tokyo Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-06-03
• Last Update Posted: 17 October 2023
• Study Completion: 2027-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who the principal investigator or co-investigator has deemed unsuitable for this study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The correlation between ultrasonic parameters (LS, DS, AC) and pathological parameters (fibrosis, lobular inflammation, steatosis).

Secondary Outcome Measures

Name	Time	Method
1.Diagnostic capability of liver fibrosis by LS (F0 vs. F1234, F01 vs. F234, F012 vs. F34, F0123 vs. F4) 2.Diagnostic capability of lobular inflammation by DS (A0 vs. A123, A01 vs. A23, A012 vs. A3) 3.Diagnostic capability of liver steatosis by AC (S0 vs. S123, S01 vs. S23, S012 vs. S3) 4.Progression of ultrasound parameters before treatment and 3, 6, 9, 12 months after treatment initiation. 5.The impact of subcutaneous thickness on ultrasound parameters (LS, DS, AC).